Article Listing - Amersham signs off 2003 with EPS up 13%

HOECHST DEFENDS NOMIFENSINE IN SUIT

16 March 1992

The German drugs major Hoechst AG is defending itself against allegations linked to claimed side effects of the company's antidepressant...

ARES-SERONO Rx DRUG SALES UP 15.5%

16 March 1992

On group sales of $751.1 million for the year ended December 31, 1991 (reported in brief last week), Swiss-based Ares-Serono...

US ORPHAN DRUG CHANGE "WOULD BE VETOED"

16 March 1992

The US Bush Administration is strongly opposed to S 2060, the Senate legislation which proposes to end the market monopoly...

FRENCH DOCTORS ATTACK COST DEAL

16 March 1992

The French general practitioners' union, MG-France, has warned of the effects which the health cost control deal just agreed between...

LIFEGrOUP CHANGES ACQUISITION PLAN

16 March 1992

After a long period of analysis and negotiation, Italy's LIFEGROUP, founded in 1991, has decided against proceeding with the planned...

PHARMA UNIT SALE LIFTS GIST-BROCADES

16 March 1992

Excluding the pharmaceuical division which it sold to Yamanouchi last year, Dutch company Gist-Brocades saw turnover for 1991 increase by...

BEECHAM WITHDRAWS TALPEN FROM UK

16 March 1992

- Beecham Pharma has withdrawn the broad spectrum penicillin antibiotic Talpen (talampicillin hydrochloride) from the UK market on grounds that...

BBG'S DETECTION KITS

16 March 1992

- British Bio-technology Prod-ucts Ltd has expanded its range of in situ hybridization products to include a Detection Module for...

TREATMENT IND FOR AGOURON'S AG-331

16 March 1992

- Oncologists have confirmed that USA-based Agouron Phar-ma's AG-331 has been effective against tumors in animals. The company plans to...

GENZYME AND GLYCOPROTEINS

16 March 1992

- Genzyme Corp, in collaboration with Robert Van Etten and colleagues at Purdue University, Indiana, has developed technol-ogy which could...

Showing 94581-94590 of 95329 articles

Go to beginningPreviousNextGo to end